23496-18-6Relevant articles and documents
Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.
Baker,Meyer Jr.
, p. 224 - 227 (2007/10/08)
-